Nasopharyngeal cancer: Is the addition of chemotherapy to radiotherapy worthwhile in an era of value-based care?

Victoria M. Villaflor; Erminia Massarelli

doi:10.1200/OP.20.00656

Nasopharyngeal cancer: Is the addition of chemotherapy to radiotherapy worthwhile in an era of value-based care?

Victoria M. Villaflor, Erminia Massarelli^*

^*Corresponding author for this work

Medicine, Hematology Oncology Division

Research output: Contribution to journal › Editorial › peer-review

1 Scopus citations

Original language	English (US)
Pages (from-to)	711-712
Number of pages	2
Journal	JCO Oncology Practice
Volume	16
Issue number	11
DOIs	https://doi.org/10.1200/OP.20.00656
State	Published - Nov 2020

ASJC Scopus subject areas

Oncology
Health Policy
Oncology(nursing)

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1200/OP.20.00656

Cite this

@article{5f1b17ca08ae408c83ab4d1f40642605,

title = "Nasopharyngeal cancer: Is the addition of chemotherapy to radiotherapy worthwhile in an era of value-based care?",

author = "Villaflor, {Victoria M.} and Erminia Massarelli",

note = "Funding Information: Bristol Myers Squibb, Novacure Research Funding: Takeda Science Foundation Travel, Accommodations, Expenses: ARIAD/Takeda, AstraZeneca, Bristol Myers Squibb, Novacure",

year = "2020",

month = nov,

doi = "10.1200/OP.20.00656",

language = "English (US)",

volume = "16",

pages = "711--712",

journal = "JCO Oncology Practice",

issn = "2688-1527",

publisher = "American Society of Clinical Oncology",

number = "11",

}

TY - JOUR

T1 - Nasopharyngeal cancer

T2 - Is the addition of chemotherapy to radiotherapy worthwhile in an era of value-based care?

AU - Villaflor, Victoria M.

AU - Massarelli, Erminia

N1 - Funding Information: Bristol Myers Squibb, Novacure Research Funding: Takeda Science Foundation Travel, Accommodations, Expenses: ARIAD/Takeda, AstraZeneca, Bristol Myers Squibb, Novacure

PY - 2020/11

Y1 - 2020/11

UR - http://www.scopus.com/inward/record.url?scp=85096152006&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85096152006&partnerID=8YFLogxK

U2 - 10.1200/OP.20.00656

DO - 10.1200/OP.20.00656

M3 - Editorial

C2 - 32946323

AN - SCOPUS:85096152006

SN - 2688-1527

VL - 16

SP - 711

EP - 712

JO - JCO Oncology Practice

JF - JCO Oncology Practice

IS - 11

ER -

Nasopharyngeal cancer: Is the addition of chemotherapy to radiotherapy worthwhile in an era of value-based care?

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Cite this